Cellistic Logo
  • CDMO Services
    • Cell Line Development
    • Process Development
    • Analytical Development
    • Master Cell Banking
    • Tech Transfer
    • GMP Manufacturing
    • QC Testing
  • Platforms & Technologies
    • Allo Chassis™
    • STAR-CRISPR™
    • Pulse Cell Line Development Platform
    • Cellistic’s Echo Manufacturing Platform
  • GMP Manufacturing
    • Echo™-NK
    • Echo™-Cardio
    • Echo™-Endothelial
    • Echo™-T
  • Facility
  • Expert Insights
    • Announcements
    • Expert Opinion
    • Interviews
    • Podcasts
    • Posters
    • Webinars
  • About
    • Team
    • Careers
    • Events
Contact
Cellistic Logo
  • CDMO Services
    • Cell Line Development
    • Process Development
    • Analytical Development
    • Master Cell Banking
    • Tech Transfer
    • GMP Manufacturing
    • QC Testing
  • Platforms & Technologies
    • Allo Chassis™
    • STAR-CRISPR™
    • Pulse Cell Line Development Platform
    • Cellistic’s Echo Manufacturing Platform
  • GMP Manufacturing
    • Echo™-NK
    • Echo™-Cardio
    • Echo™-Endothelial
    • Echo™-T
  • Facility
  • Expert Insights
    • Announcements
    • Expert Opinion
    • Interviews
    • Podcasts
    • Posters
    • Webinars
  • About
    • Team
    • Careers
    • Events

Expert Opinion

All Announcements Events Expert Opinion Interviews Podcasts Posters Webinars
Gene-edited iPSC: the role of Automation in Cell Line Development

February 14, 2025

Gene-edited iPSC: the role of Automation in Cell Line Development

Precise gene editing is crucial for the development of cell-based therapies, particularly ...

iPSC-Derived Allogeneic Cell Therapies and Cloaking: Mechanisms, Importance and Strategies

February 5, 2025

iPSC-Derived Allogeneic Cell Therapies and Cloaking: Mechanisms, ...

Induced pluripotent stem cell (iPSC)-derived allogeneic cell therapies hold significant ...

Development and characterization of iPSC-derived regulatory T cells – Towards an allogenic cell therapy for the treatment of autoimmunity and inflammatory conditions

December 3, 2024

Development and characterization of iPSC-derived regulatory T cells – ...

Regulatory T cells (Tregs) play a pivotal role in maintaining immune homeostasis and ...

Enhanced control of iPS cell critical quality attributes through analytical characterisation

September 30, 2024

Enhanced control of iPS cell critical quality attributes through ...

Summary of the Whitepaper on Building Blocks for Cell & Gene Therapy (CGT)

July 8, 2024

Summary of the Whitepaper on Building Blocks for Cell & Gene Therapy (CGT)

The whitepaper, a collaboration between the Alliance for Regenerative Medicine (ARM) and the ...

IP Considerations for Gene Editing in the Cell Therapy space

June 10, 2024

IP Considerations for Gene Editing in the Cell Therapy space

Gene editing for cell therapies and, in particular, for iPSC-derived cell therapies have ...

← 1 2 3 →
Cellistic Logo White
  • Services
  • Technologies
  • Cell Types
  • Facility
  • Resources
  • About
  • Contact
  • Team
  • Careers
x-twitter InBug-White-1

Rue Edouard Belin 2
1435 Mont-Saint-Guibert
Belgium

 

partnering@cellistic.com

  • Privacy Policy
  • Cookie Policy